Edmund V Capparelli Selected Research

Edmund V Capparelli Research Topics

Disease

13	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 01/2003
12	Infections 12/2021 - 04/2003
12	Body Weight (Weight, Body) 01/2021 - 03/2005
10	HIV Infections (HIV Infection) 01/2021 - 12/2011
6	Seizures (Absence Seizure) 11/2019 - 03/2010
5	Tuberculosis (Tuberculoses) 05/2022 - 01/2017
4	Neoplasms (Cancer) 01/2022 - 04/2012
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 02/2003
4	Pain (Aches) 01/2016 - 06/2005
3	Birth Weight (Birth Weights) 01/2022 - 01/2016
3	Sepsis (Septicemia) 01/2020 - 10/2005
3	Status Epilepticus (Complex Partial Status Epilepticus) 11/2018 - 04/2012
3	Intraabdominal Infections 09/2013 - 10/2011
2	Coinfection 05/2022 - 01/2019
2	Leprosy (Hansen's Disease) 12/2021 - 12/2021
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2021 - 12/2021
2	Malaria 01/2021 - 02/2011
2	Neutropenia 01/2021 - 01/2015
2	Low Back Pain (Lumbago) 01/2020 - 01/2016
2	Back Pain (Backache) 01/2020 - 04/2007
2	Critical Illness (Critically Ill) 01/2020 - 12/2012
2	Headache (Headaches) 10/2019 - 03/2015
2	Invasive Candidiasis 12/2017 - 01/2016
2	Exanthema (Rash) 08/2016 - 03/2015
2	Diarrhea 08/2016 - 03/2015
1	Leukemia 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	COVID-19 12/2021
1	Peritonitis 01/2021
1	Parasitemia 01/2021
1	AIDS-Related Complex (ARC) 01/2020
1	Schistosomiasis (Bilharziasis) 01/2020

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 05/2022 - 03/2006
8	Ritonavir (Norvir)FDA Link 05/2022 - 12/2007
6	Lopinavir FDA Link 05/2022 - 12/2007
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 02/2003
5	efavirenz (Sustiva)FDA Link 01/2022 - 12/2007
4	Monoclonal AntibodiesIBA 01/2021 - 12/2008
4	Nevirapine (Viramune)FDA Link 01/2021 - 02/2007
4	Meropenem (Merrem)FDA LinkGeneric 01/2020 - 10/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2008
3	Infliximab (Remicade)FDA Link 01/2022 - 12/2008
3	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 09/2008
3	Vancomycin FDA LinkGeneric 01/2021 - 01/2014
3	TabletsIBA 01/2018 - 08/2010
3	Fluconazole (Zonal)FDA LinkGeneric 12/2017 - 10/2012
3	Reverse Transcriptase InhibitorsIBA 01/2017 - 10/2012
3	Lamivudine (Epivir)FDA Link 03/2015 - 12/2007
2	Clofazimine (Lamprene)FDA Link 12/2021 - 12/2021
2	CreatinineIBA 01/2021 - 01/2018
2	Tenofovir (Viread)FDA Link 01/2021 - 04/2011
2	AlbuminsIBA 01/2021 - 11/2019
2	Desipramine (Pertofrane)FDA LinkGeneric 01/2020 - 04/2007
2	Benztropine (Benzatropine)FDA LinkGeneric 01/2020 - 04/2007
2	Phenobarbital (Luminal)FDA Link 11/2019 - 07/2012
2	Levetiracetam (Keppra)FDA LinkGeneric 11/2019 - 07/2012
2	Rilpivirine (TMC-278)IBA 01/2018 - 01/2016
2	BilirubinIBA 01/2018 - 12/2012
2	Antifungal AgentsIBA 12/2017 - 06/2014
2	NucleosidesIBA 01/2017 - 12/2012
2	Lorazepam (Ativan)FDA LinkGeneric 01/2017 - 04/2012
2	Antiviral Agents (Antivirals)IBA 11/2016 - 02/2011
2	abacavir (Ziagen)FDA Link 03/2015 - 02/2006
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 02/2011 - 03/2008
2	FluoroquinolonesIBA 04/2007 - 03/2005
2	Gatifloxacin (Zymar)FDA Link 04/2007 - 03/2005
2	SuspensionsIBA 04/2007 - 03/2005
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2022
1	InterleukinsIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	GlycopeptidesIBA 01/2021
1	CIS43LSIBA 01/2021
1	Cefepime (Maxipime)FDA LinkGeneric 01/2021
1	First Generation CephalosporinsIBA 01/2021
1	AminoglycosidesIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020
1	Praziquantel (Biltricide)FDA Link 01/2020
1	ThymidineIBA 01/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 03/2006
4	Highly Active Antiretroviral Therapy (HAART) 12/2012 - 12/2007
3	Art Therapy 01/2021 - 02/2011
2	Intravenous Infusions 01/2017 - 10/2005
2	Analgesia 01/2016 - 03/2006
1	Precision Medicine 01/2022
1	Injections 01/2022
1	Liver Transplantation 10/2021
1	Catheters 01/2021
1	Peritoneal Dialysis 01/2021
1	Mass Drug Administration 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Oral Administration 01/2020